Benefix 1,000 unit ranges
Ended Awarded Last action
- Contract number
- SPE2DR26FFBS7
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,070
Award facts
- Contract value 100% obligated
- $14,070.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $14,070.40 firm fixed-price delivery order (4570376199) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for 1,000-unit ranges of BENEFIX products. The award, issued on December 23, 2025, with an ultimate completion date of January 15, 2026, carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. This delivery order is issued under DMS Pharmaceutical Group's Indefinite Delivery Contract (SPE2DR) with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a $30.3 billion acquisition strategy designed to streamline pharmaceutical supply chains across Department of Defense healthcare facilities worldwide.
DMS Pharmaceutical Group serves as a critical supplier within the federal pharmaceutical supply chain, leveraging its small business status and established performance record to distribute a comprehensive range of pharmaceutical products and medical consumables to military healthcare operations. The company's IDC, awarded on November 13, 2025, with a $499,999,999 ceiling and completion date of December 31, 2036, authorizes DLA to issue firm fixed-price delivery orders for branded and generic prescription drugs, over-the-counter medications, biologics, vaccines, and medical consumables. The contractor's demonstrated capability spans diverse therapeutic categories including oncology treatments, immunosuppressants, emergency medications, and specialty surgical products, positioning it as a key pharmaceutical vendor for Department of Defense global medical supply requirements.
Quick answers
Who was awarded contract SPE2DR26FFBS7?
SPE2DR26FFBS7 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 23, 2025.
How much is contract SPE2DR26FFBS7 worth?
The government has obligated $14,070 on SPE2DR26FFBS7.
Is contract SPE2DR26FFBS7 an order under another contract?
Yes. SPE2DR26FFBS7 is a delivery order under SPE2DR25D9239, an indefinite delivery contract.
Was contract SPE2DR26FFBS7 competed?
The extent of competition for SPE2DR26FFBS7 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award